Multi-center retrospective study of prognostic significance of histological subtypes and expression of immunomolecules in adenocarcinoma of the uterine cervix

Multi-center retrospective study of prognostic significance of histological subtypes and expression of immunomolecules in adenocarcinoma of the uterine cervix - Prognostic significance of histological subtypes and expression of immunomolecules in adenocarcinoma of the uterine cervix

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027823

Enrollment

150

Registered

2017-06-19

Start date

2017-01-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenocacinoma of the uterine cervix

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: (1)Adenocarcinoma of the uterine cervix (2)treated with definitive radiotherapy in the institutions between 2000 and 2016

Exclusion criteria

Exclusion criteria: (1)prior treatment (2)no bioptic sample (3)other malignancies (except no recurrence cases 5 years after definitive treatments)

Design outcomes

Primary

Measure	Time frame
5-year overall survival	—

Countries

Japan

Contacts

Public ContactYuya YOSHIMOTO

Gunma university hospital department of radiation oncology

yuyayoshimoto@gunma-u.ac.jp+81-27-220-8383

Outcome results